Weight Loss and Obesity Management Market (By Drug Type- Peripherally Acting Drugs and Centrally Acting Drugs. By Distribution Channel- Hypermarkets/ Supermarkets, Pharmaceutical Stores and Online Market. By Type- Over-The-Counter Drugs and Prescription Drugs. By Duration of Therapy- Short-Term Drugs and Long-Term Drugs) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2021-2031

The ‘Global Weight Loss and Obesity Management Market’ was valued at $212 Billion in 2020 and is expected to reach $490.1 Billion 2031 at the CAGR of 7.4% between 2021 and 2031 

Weight Loss and Obesity Medications Market are medicines which help to control or reduce weight. Although the main treatment for overweight is dieting and physical exercise. Obesity or overweight is a chronic condition which requires a long-term management scheme. Obesity is mainly a relapsing and chronic disease in which the body fat accumulates in one place. Increasing health risks associated with obesity includes risk for diabetes, hypertension, heart disease and other metabolic disturbances. Moreover, psychological problems like clinical depression are also related with obesity which may affect the quality of life. Additionally, factors influencing body weight of some individuals includes ethnicity, gender, age, hormonal state and genetic make-up. Lack of exercise, mobility and activity rises the risk of obesity in an individual. Increasing prevalence of overweight and obesity all across the globe, makes the medications market more demanding. Popular drugs such as acarbose and metformin are useful for weight loss. Weight loss or obesity medicines contain ingredients such as fiber, herbs and minerals in many combinations and in different amounts. These medications are sold in the market in form of capsules, liquids, tablets and powders. The significant health benefits associated with the weight loss or obesity medications, drives the growth of this market during the projection period of 2021-2031.

Weight loss or obesity medications provide several benefits among consumers. Some of the benefits include providing essential nutrients in human body and maintaining cholesterol levels.Adoption of such anti-obesity or weight loss drugs by men and women and their rising awareness towards their health creates a huge market growth opportunity for global Weight Loss and Obesity Management market. Further down, obesity or overweight is also considered as a threat for development of several chronic diseases such as hypertension, dyslipidemia, coronary heart disease, metabolic disorders and cancer. Prevention of such kind of diseases related to obesity or overweight, creates an ample growth opportunity of this market over the next eight years.

Download Free PDF Sample Request

The drug types of weight loss or obesity medications mentioned in the report includes peripherally acting drugs and centrally acting drugs.TheWeight Loss and Obesity Managementmarket in report is segmented by type which includes over-the-counter drugs and prescription drugs. Moreover, on the basis of distribution channel, the market has been segmented as hypermarkets/ supermarkets, pharmaceutical stores and online market.Further down, the weight loss or obesitymedications markethas been segmented by duration of therapy which includes short-term drugs and long-term drugs. The globalWeight Loss and Obesity Management market has been moreover segmented geographically into North America, Europe, Asia-Pacific, Middle East and Africa and Latin America.

Product developmentand huge expenditurein the research and development sector by leading vendors has made the market more demanding in recent years. However, nausea, anxiety and depression are some of the side effects of these medicines which is expected to hamper the market growth of weight loss or obesity medications in near future.

Some of the major players in the global weight loss or obesity medications market include Orexigen Therapeutics Inc., Norgine B.V., Amway Enterprises, Merck & Co. Inc., Pfizer Inc., and few likely to be named.

Scope of the Report:

The Global Weight Loss and Obesity Management Market has been segmented into:

Global Weight Loss or Obesity Medications Market: By Drug Type

• Peripherally Acting Drugs
• Centrally Acting Drugs

Global Weight Loss or Obesity Medications Market: By Distribution Channel

• Hypermarket/ Supermarket
• Pharmaceutical Stores
• Online Market

Global Weight Loss or Obesity Medications Market: By Type

• Over-The-Counter Drugs
• Prescription Drugs

Global Weight Loss or Obesity Medications Market: By Duration of Therapy

• Short-Term Drugs
• Long-Term Drugs

Global Weight Loss or Obesity Medications Market: By Geography

• North America
• U.S.
• Canada
• Mexico
• Europe
• U.K.
• France
• Germany
• Italy
• Rest of Europe
• Asia Pacific
• India
• China
• Japan
• Rest of Asia Pacific
• Middle East and Africa
• South Africa
• Rest of Middle East and Africa
• Latin America
• Brazil
• Rest of Latin America